AstraZeneca Licenses Novel Lung Cancer Drug Zegfrovy in $1.5B Global Deal
AstraZeneca announced a exclusive global license agreement with Dizal Pharmaceutical to develop and commercialize Zegfrovy (sunvozertinib), a highly differentiated, oral irreversible EGFR inhibitor designed for targeted lung cancer...
VerGo Pharma Successfully Concludes Unannounced US FDA Inspection with Zero Observations
VerGo Pharma, a leading Contract Research Organization (CRO), announced the successful completion of an unannounced United States Food and Drug Administration (US FDA) inspection at...
Warburg Pincus Acquires Integrace Private Ltd for ₹1,000 Crore
Global private equity firm Warburg Pincus has successfully completed the acquisition of domestic pharmaceuticals company Integrace Private Ltd from existing shareholders True North and Temasek. While official financial details...
Dr. Reddy’s Announces First-to-Market Launch of Generic Bosulif®️ Tablets in the U.S.
Dr. Reddy’s Laboratories Ltd. has launched Bosutinib Tablets 400mg, a first-to-market generic equivalent of Wyeth LLC’s Bosulif®, in the United States. As a first-to-file product,...
Sports Injury Centre and SAI Sign Landmark MoU for Athlete Care
In a major boost to the nation’s sports ecosystem, the Sports Injury Centre (SIC) at Safdarjung Hospital and the Sports Authority of India (SAI) have signed...
Glenmark Pharmaceuticals Inc., USA Launches Olanzapine for Injection
Glenmark Pharmaceuticals Inc., USA (Glenmark) has announced the official launch of Olanzapine for Injection, 10mg/vial, available as a Single-Dose Vial.
The newly launched product is bioequivalent...
